MXC-30839-02127 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-27
Dose 1 — Pfizer-BioNTech
2021-01-18
Registered in v-safe
2021-01-18
Dose 2 — Pfizer-BioNTech
2021-01-18
Health check-in — day 0, dose 2
Feeling: Good · Chills, Fatigue or tiredness

Adult check-in
2021-01-19
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work

Adult check-in
2021-01-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-01-24
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-25
Health check-in — day 7, dose 2
Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-02-01
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 35, dose 2
Feeling: Fair

Adult check-in
2021-03-01
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-19
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-19
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-09-29
Dose 3 — Pfizer-BioNTech
2021-09-29
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-09-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-10-01
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-10-02
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-10-03
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-10-04
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache

Adult check-in
2021-10-05
Health check-in — days 1–6 daily, dose 3
Feeling: Good · Headache

Adult check-in
2021-10-06
Health check-in — day 7, dose 3
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-10-13
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-10-21
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-10-27
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-11-03
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-10
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-04-01
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-29
Survey response — 12 months, dose 3
MedDRA: Dyspnoea — Feeling: Good · Be unable to work or attend school

Free text: Shortness of breath

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-27	Pfizer-BioNTech
2	2021-01-18	Pfizer-BioNTech
3	2021-09-29	Pfizer-BioNTech	No

Free text

Release 12 — 12 months, dose 3

2022-09-29

Symptoms: Shortness of breath

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dyspnoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release